{
  "first_published_at": "2014-09-25", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON452541", 
  "title": "Domperidone: risk of cardiac side effects â€“ no longer available without prescription", 
  "tags": "{\"parsed_therapeutic\": [\"gi-hepatology-pancreatic-disorders\", \"nutrition-dietetics\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"GI, hepatology and pancreatic disorders\", \"Nutrition and dietetics\"]}", 
  "_document_number": 13, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/legal_icon.png", 
  "therapeutic_area": [
    "gi-hepatology-pancreatic-disorders", 
    "nutrition-dietetics"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Domperidone: risk of cardiac side effects &#8211; no longer available without prescription</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: September 2014</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--Domperidone should no longer be sold to anyone without a prescription. It is associated with a small increased risk of serious cardiac side effects.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Domperidone is a dopamine antagonist with antiemetic properties. It should no longer be sold to anyone without a prescription. It is associated with a small increased risk of serious cardiac side effects (eg, QTc prolongation, torsade de pointes, serious ventricular arrhythmia, and sudden cardiac death). Therefore people need to have a medical assessment before taking domperidone to determine if it is suitable for them.</p>\n\n<div class=\"dull_highlight\">\n<p><strong>Advice for healthcare professionals</strong></p>\n\n<ul type=\"disc\">\n<li>Domperidone must not be sold without prescription</li>\n\n<li>A <a href=\"https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218\" target=\"_blank\">recall</a> has been issued for non-prescription domperidone (Motilium 10 and Motilium instants)</li>\n\n<li>Take into account the updated prescription advice before prescribing domperidone (see Drug Safety Update article from <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON418518\" target=\"_blank\">May 2014</a>)</li>\n</ul>\n\n<p><strong>Advice to give to patients</strong></p>\n\n<ul>\n<li>If you have recently bought domperidone without a prescription and you wish to continue taking it, speak to your doctor or pharmacist at your next routine visit. There is no problem if you wish to stop and a healthcare professional can advise on suitable alternatives for nausea and vomiting.</li>\n\n<li>If you have been prescribed domperidone, there is no need to stop taking it. Speak to your doctor or pharmacist at your next routine visit if you have any heart problems or other concerns about the treatment.</li>\n\n<li>Talk to a doctor straight away if you experience dizziness; fainting; chest pain; or a rapid, fluttering, or pounding heartbeat while taking domperidone.</li>\n</ul>\n</div>\n\n<p><img src=\"/home/groups/dsu/documents/publication/con454362.jpg\" alt=\"motilium packs image\" border=\"0\" width=\"458\" height=\"140\" /></p>\n\n<p>Figure: A <a href=\"https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218\" target=\"_blank\">recall</a> has been issued for non-prescription domperidone (Motilium 10 and Motilium instants)</p>\n\n<p><strong>Further information</strong></p>\n\n<p><a target=\"_blank\" href=\"/Opendocuments/OpenPDFdocuments/CON454364\">Further information to give to patients</a></p>\n\n<p><a href=\"https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218\" target=\"_blank\">Drug alert </a>issued on 3 September 2014</p>\n\n<p><a href=\"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON452546\" target=\"_blank\">MHRA press release</a> issued on 3 September 2014&#160;</p>\n\n<p><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Domperidone_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500168926.pdf \" target=\"_blank\">Pharmacovigilance Risk Assessment Committee (PRAC) assessment report</a></p>\n\n<p><em>Article citation: Drug Safety Update volume 8 issue 2, September 2014: S1</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Domperidone is a dopamine antagonist with antiemetic properties. It should no longer be sold to anyone without a prescription. It is associated with a small increased risk of serious cardiac side effects (eg, QTc prolongation, torsade de pointes, serious ventricular arrhythmia, and sudden cardiac death). Therefore people need to have a medical assessment before taking domperidone to determine if it is suitable for them.</p>\n\n<div class=\"dull_highlight\">\n<p><strong>Advice for healthcare professionals</strong></p>\n\n<ul type=\"disc\">\n<li>Domperidone must not be sold without prescription</li>\n\n<li>A <a href=\"https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218\" target=\"_blank\">recall</a> has been issued for non-prescription domperidone (Motilium 10 and Motilium instants)</li>\n\n<li>Take into account the updated prescription advice before prescribing domperidone (see Drug Safety Update article from <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON418518\" target=\"_blank\">May 2014</a>)</li>\n</ul>\n\n<p><strong>Advice to give to patients</strong></p>\n\n<ul>\n<li>If you have recently bought domperidone without a prescription and you wish to continue taking it, speak to your doctor or pharmacist at your next routine visit. There is no problem if you wish to stop and a healthcare professional can advise on suitable alternatives for nausea and vomiting.</li>\n\n<li>If you have been prescribed domperidone, there is no need to stop taking it. Speak to your doctor or pharmacist at your next routine visit if you have any heart problems or other concerns about the treatment.</li>\n\n<li>Talk to a doctor straight away if you experience dizziness; fainting; chest pain; or a rapid, fluttering, or pounding heartbeat while taking domperidone.</li>\n</ul>\n</div>\n\n<p><img src=\"http://www.mhra.gov.uk/home/groups/dsu/documents/publication/con454362.jpg\" alt=\"motilium packs image\" border=\"0\" width=\"458\" height=\"140\"></p>\n\n<p>Figure: A <a href=\"https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218\" target=\"_blank\">recall</a> has been issued for non-prescription domperidone (Motilium 10 and Motilium instants)</p>\n\n<p><strong>Further information</strong></p>\n\n<p><a target=\"_blank\" href=\"http://www.mhra.gov.uk/Opendocuments/OpenPDFdocuments/CON454364\">Further information to give to patients</a></p>\n\n<p><a href=\"https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218\" target=\"_blank\">Drug alert</a>issued on 3 September 2014</p>\n\n<p><a href=\"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON452546\" target=\"_blank\">MHRA press release</a> issued on 3 September 2014&#160;</p>\n\n<p><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Domperidone_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500168926.pdf\" target=\"_blank\">Pharmacovigilance Risk Assessment Committee (PRAC) assessment report</a></p>\n\n<p><em>Article citation: Drug Safety Update volume 8 issue 2, September 2014: S1</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2014-09-01", 
  "date_last_modified": "2014-09-24", 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Further information to give to patients", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/Opendocuments/OpenPDFdocuments/CON454364", 
      "filename": "downloads/7f739c8be548bff597225c0a3f5b12d26d2a20f5/con454364.pdf", 
      "original_filename": "con454364.pdf"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "motilium packs image", 
      "assetid": 1, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dsu/documents/publication/con454362.jpg", 
      "filename": "downloads/cde77a1014346d091fc8f9b976839bc65b951464/con454362.jpg", 
      "original_filename": "con454362.jpg"
    }
  ], 
  "_item_id": 13, 
  "summary": "", 
  "body": "Article date: September 2014\n\nDomperidone is a dopamine antagonist with antiemetic properties. It should no longer be sold to anyone without a prescription. It is associated with a small increased risk of serious cardiac side effects (eg, QTc prolongation, torsade de pointes, serious ventricular arrhythmia, and sudden cardiac death). Therefore people need to have a medical assessment before taking domperidone to determine if it is suitable for them.\n\nAdvice for healthcare professionals  \n  \n  * Domperidone must not be sold without prescription  \n  * A [recall](https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218) has been issued for non-prescription domperidone (Motilium 10 and Motilium instants)  \n  * Take into account the updated prescription advice before prescribing domperidone (see Drug Safety Update article from [May 2014](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON418518))  \n  \nAdvice to give to patients  \n  \n  * If you have recently bought domperidone without a prescription and you wish to continue taking it, speak to your doctor or pharmacist at your next routine visit. There is no problem if you wish to stop and a healthcare professional can advise on suitable alternatives for nausea and vomiting.  \n  * If you have been prescribed domperidone, there is no need to stop taking it. Speak to your doctor or pharmacist at your next routine visit if you have any heart problems or other concerns about the treatment.  \n  * Talk to a doctor straight away if you experience dizziness; fainting; chest pain; or a rapid, fluttering, or pounding heartbeat while taking domperidone.  \n  \n![ASSET_TAG](#ASSET1)\n\nFigure: A [recall](https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218) has been issued for non-prescription domperidone (Motilium 10 and Motilium instants)\n\nFurther information\n\n[ASSET_TAG](#ASSET0)\n\n[Drug alert](https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102218)issued on 3 September 2014\n\n[MHRA press release](http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON452546) issued on 3 September 2014Â \n\n[Pharmacovigilance Risk Assessment Committee (PRAC) assessment report](http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Domperidone_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500168926.pdf)\n\nArticle citation: Drug Safety Update volume 8 issue 2, September 2014: S1\n"
}